myFibroScan - Google Play
You'll be able to see results in few seconds.
Publisher Description
Your everyday FibroScan® companion
FibroScan® is the non-invasive gold standard solution for comprehensive management of liver health.
FibroScan® is powered by three unique, patented and validated biomarkers, LSM by VCTE™ (Liver Stiffness Measurement) and CAP™ (Controlled Attenuation Parameter) that benefit from a worldwide clinical evidence with over 5300+ peer-reviewed publications and 180+ international guidelines.
myFibroScan app is your everyday FibroScan® companion to access Interpretation Guide and FibroScan® based scores in an easy, fast and intuitive way :
The Interpretation Guide utilizes data from clinical studies to assist providers in interpreting FibroScan® examination results.
Scores enhance FibroScan® liver disease assessment with biological markers.
Scores are presented as educational services intended for licensed healthcare professionals. While the scores are about specific medical and healthcare issues, they are not a substitute for/or replacement of personalized medical advice and are not intended to be used as the sole basis for making individualized medical or health-related decisions.
• Fast is an aid to identify at risk MASH patients defined as MASH + NAS≥4 + F≥2. Good to excellent performance in cohorts from different clinical settings (MASLD tertiary care unit, screening, bariatric surgery) and geographical origins (USA, Europe, Asia). Several publications advocate the use of Fast.
• Agile 3+ is an aid to identify MASLD patients with advanced fibrosis by combining LSM by VCTE™ and routine clinical parameters to reduce the need for liver biopsy. High clinical performances are demonstrated in large external validation cohorts from different geographical origins.
• Agile 4 is an aid to early identify MASLD patients with cirrhosis by combining LSM by VCTE™ and routine clinical parameters. It can help the physicians to manage the disease to prevent liver-related complications such as hepatocellular carcinoma. High clinical performances are demonstrated in large external validation cohorts from different geographical origin.
MASH Treatment Eligibility Tool to eliminate the Guesswork.
This patient management tool embeds treatment recommendations based on the patient’s FibroScan® results and the latest AASLD Guidance.
About myFibroScan
The company that develops myFibroScan is Liver-IT. The latest version released by its developer is 1.0 .
To install myFibroScan on your Android device, just click the green Continue To App button above to start the installation process. The app is listed on our website since 2025-10-24 and was downloaded 0 times. We have already checked if the download link is safe, however for your own protection we recommend that you scan the downloaded app with your antivirus. Your antivirus may detect the myFibroScan as malware as malware if the download link to com.echosens.Echosens.MyFibroScan is broken.
How to install myFibroScan on your Android device:
- Click on the Continue To App button on our website. This will redirect you to Google Play.
- Once the myFibroScan is shown in the Google Play listing of your Android device, you can start its download and installation. Tap on the Install button located below the search bar and to the right of the app icon.
- A pop-up window with the permissions required by myFibroScan will be shown. Click on Accept to continue the process.
- myFibroScan will be downloaded onto your device, displaying a progress. Once the download completes, the installation will start and you'll get a notification after the installation is finished.
Program Details
System requirements
Download information
Pricing
Version History
version
posted on 2025-10-24
myFibroScan, your Everyday FibroScan® Companion, evolves to bring you:
•Updated Clinical References: The Interpretation Guide now includes the most recent publications, ensuring the tool reflects the latest clinical knowledge.
•New MASH Treatment Eligibility Tool (USA only): Take the guesswork out of patient management. This new feature integrates treatment recommendations based on FibroScan® results and the latest AASLD Guidance.
•Translated in Italian
version 2.4.0
posted on 2024-10-28
Update target Android version to run on Android 14
Disclaimer
Official Google Play Link
We do not host myFibroScan on our servers. We did not scan it for viruses, adware, spyware or other type of malware. This app is hosted by Google and passed their terms and conditions to be listed there. We recommend caution when installing it.
The Google Play link for myFibroScan is provided to you by apps112.com without any warranties, representations or guarantees of any kind, so access it at your own risk.
If you have questions regarding this particular app contact the publisher directly. For questions about the functionalities of apps112.com contact us.
